Cilostazol
- Product NDC
- 0093-2065
- 11-digit product format
- 000932065
- Labeler code
- 0093
- Product ID
- 0093-2065_01457771-0b8c-4f1b-8513-01ad09ac97cc
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Cilostazol
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Teva Pharmaceuticals USA, Inc.
- Application
- ANDA077027
- Marketing category
- ANDA
- Marketing start
- 2012-04-24
- Substance
- CILOSTAZOL
- Active strength
- 50 mg/1
- Pharmacologic classes
- Phosphodiesterase 3 Inhibitor [EPC], Phosphodiesterase 3 Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Cilostazol
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| CILOSTAZOL | 50 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | N7Z035406B |
| Rxcui | 242461, 242462 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 0093-2065-06 | Cilostazol | 60 in 1 BOTTLE | TABLET | 60 | | 16 |
DailyMed Socrata Ingredients#
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 0093-2065 | CILOSTAZOL TABLET [TEVA PHARMACEUTICALS USA, INC.] | 16 | Current NDC, Legacy NDC, 1 package rows | 20230329_a6292311-9cb2-49ff-b8bf-12e2dbd196cd.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 0093-2065-06 | 00093206506 | 60 TABLET in 1 BOTTLE (0093-2065-06) | 60 tablet | 2012-04-24 | 0000-00-00 | No | No | Current |